Ipca Laboratories Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 524494 |
NSE Symbol : IPCALAB |
P/E(TTM) : 64.16 |
ISIN Demat : INE571A01038 |
Div & Yield% : 0.26 |
EPS(TTM) : 24.27 |
Book Value(₹) : 250.24 |
Market Cap(₹Cr) : 39,505.55 |
Face Value(₹) : 1.00 |
Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.27 |
Reserves | 6,323.34 | 5,851.93 | 5,450.39 | 4,727.35 | 3,640.33 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 11.94 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 6,348.71 | 5,877.30 | 5,475.76 | 4,752.72 | 3,677.54 |
Secured Loans | 990.54 | 857.91 | 554.57 | 113.53 | 298.19 |
Unsecured Loans | 161.28 | 582.47 | 221.84 | 122.72 | 176.26 |
Total Debt | 1,151.82 | 1,440.38 | 776.41 | 236.25 | 474.45 |
Other Liabilities | 50.61 | 46.85 | 44.33 | 39.44 | 33.24 |
Total Liabilities | 7,551.14 | 7,364.53 | 6,296.50 | 5,028.41 | 4,185.23 |
APPLICATION OF FUNDS : | |||||
Gross Block | 4,165.82 | 3,889.09 | 3,364.68 | 2,899.27 | 2,688.79 |
Less: Accumulated Depreciation | 1,642.12 | 1,410.43 | 1,211.59 | 1,030.67 | 847.82 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 2,523.70 | 2,478.66 | 2,153.09 | 1,868.60 | 1,840.97 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 175.20 | 123.02 | 297.15 | 182.00 | 84.19 |
Investments | 2,654.16 | 1,056.73 | 1,338.70 | 867.84 | 648.72 |
Current Assets, Loans & Advances | |||||
Inventories | 1,677.09 | 1,660.13 | 1,779.54 | 1,517.09 | 1,266.96 |
Sundry Debtors | 1,027.40 | 925.90 | 824.30 | 774.46 | 839.13 |
Cash and Bank Balance | 112.92 | 1,706.06 | 595.50 | 306.92 | 152.40 |
Loans and Advances | 281.88 | 259.74 | 305.81 | 285.49 | 215.37 |
Total Current Assets | 3,099.29 | 4,551.83 | 3,505.15 | 2,883.96 | 2,473.86 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 782.48 | 773.37 | 866.28 | 733.57 | 758.95 |
Provisions | 142.56 | 129.62 | 117.15 | 113.15 | 99.60 |
Total CL & Provisions | 925.04 | 902.99 | 983.43 | 846.72 | 858.55 |
Net Current Assets | 2,174.25 | 3,648.84 | 2,521.72 | 2,037.24 | 1,615.31 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 23.17 | 18.52 | 101.48 | 88.44 | 85.50 |
Deferred Tax Liability | 206.26 | 197.97 | 259.99 | 223.44 | 226.29 |
Net Deferred Tax | -183.09 | -179.45 | -158.51 | -135.00 | -140.79 |
Other Assets | 206.92 | 236.73 | 144.35 | 207.73 | 136.83 |
Total Assets | 7,551.14 | 7,364.53 | 6,296.50 | 5,028.41 | 4,185.23 |
Contingent Liabilities | 124.51 | 1,996.35 | 103.39 | 86.68 | 64.78 |